title: Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.
authors.affiliation: Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, München, Germany; Helmholtz Zentrum München - German Research Center for Environmental Health, München, Germany. daniel.heinrich@med.uni-muenchen.de.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Heinrich
authors.forename: Marc
authors.initials: M
authors.lastname: Weinkauf
authors.forename: Grit
authors.initials: G
authors.lastname: Hutter
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Zimmermann
authors.forename: Vindi
authors.initials: V
authors.lastname: Jurinovic
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Hiddemann
authors.forename: Martin
authors.initials: M
authors.lastname: Dreyling
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use; D000918:Antibody Specificity; D018951:Antigens, CD20 / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D045744:Cell Line, Tumor; D004357:Drug Synergism; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics; D000069283:Rituximab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D009363:Neoplasm Proteins; D000069283:Rituximab; C543332:obinutuzumab
keywords: anti-CD20; mantle cell lymphoma; monoclonal antibodies; obinutuzumab; rituximab